中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 8
Aug.  2024
Turn off MathJax
Article Contents

Efficacy and safety of tyrosine kinase inhibitor combined with immune checkpoint inhibitor as the second-line therapy for advanced hepatocellular carcinoma

DOI: 10.12449/JCH240818
Research funding:

The Key R & D Plan Project of Jiangsu Provincial Department of Science and Technology (BE2021648)

More Information
  • Corresponding author: ZHU Xiaoli, zhuxiaoli90@163.com (ORCID: 000-0002-3507-2018)
  • Received Date: 2023-11-13
  • Accepted Date: 2023-11-30
  • Published Date: 2024-08-25

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(3)

    Article Metrics

    Article views (304) PDF downloads(30) Cited by(1)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return